entertainment -WSS

entertainment

author：knowledge 2025-08-23 08:57:28 - browse：619

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Cassava Sciences’ Alzheimer’s clinical trials should be halted

WSS

STAT Summit: Ending the crisis of Black deaths in the U.S.

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Pandemic and All Hazards Preparedness Act needs lean update

ACA's risk program benefits Blue Cross Blue Shield insurers

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

STAT Summit: Ending the crisis of Black deaths in the U.S.

leisure time

entertainment

hotspot

In Memoriam: Notable people who died in 2023

ACA's risk program benefits Blue Cross Blue Shield insurers

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Parents surprise family after baby discharged from NICU after 170 days

Trump demands the U.S. pay no more for drugs than other countries … again

Health tech investors get more selective as pandemic boom fades

Medicare proposal to cover medical devices draws a mixed reaction

ADCs take center stage as promising cancer treatments

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The U.S. needs a new definition of substance use “recovery”

focus

Roche drug slashes death risk in early

Parents surprise family after baby discharged from NICU after 170 days

Readout LOUD podcast: Live from the 2023 STAT Summit

Wisconsin governor employs partial veto to fund schools for 4 centuries

Teachers share how revamped forgiveness program helped with their student loans

Swim instructor mom warns parents not to buy blue swimsuits for kids

focus

leisure time

Wikipedia

entertainment